Identification of Bordetella holmesii among the patients hospitalized with suspicion of pertussis and pertussis-like illnesses

Purpose. To reveal and estimate prevalence of B. holmesii among the patients hospitalized with suspicion pertussis and pertussis-like illnesses.

Materials and methods. 424 clinical samples received from patients with of pertussis and pertussis-like illnesses in GBUZ IKB № 1 DZM in 2017–2018 are investigated. Identification of fragments of a genome of Bordetella was carried out in PCR-RT with “Amplisens® Bordetella multi-FL”. For identification of fragments of a genome of B. holmesii used PCR-RT with primers of IS481, IS1001 and hIS1001.

Results. The research included 424 patients, from them 56,1% of children aged till 1 year, 41,3% of children – are more senior than 1 year and 2,6% of adults. When using test system 60,4% of the samples containing DNA of B. pertussis are revealed; 1,9% of samples – DNA of B. parapertussis; in 34,9% of samples it is received negative and in 2,8% – doubtful results. The research of 424 samples in PCR-RT by means of IS481, IS1001 and hIS1001 primers showed that 61,1% of samples contained DNA of B. pertussis; 0,7% of samples – DNA of B. parapertussis and 3,8% of samples – DNA of B. holmesii. In 143 samples the result was negative. From 16 DNA of B. holmesii – positive samples, 9 samples were negative in test system earlier, in 2 samples – the doubtful result, 1 sample was earlier identified as DNA of B. parapertussis and in 4 samples DNA of B. pertussis and B. holmesii are found.

Conclusion. The research demonstrates circulation of B. holmesii in the territory of Russia that is confirmed by identification of positive samples in 3,8% of cases among the sick children and adults hospitalized in a hospital with suspicion of pertussis and pertussis-like illnesses. For increase in efficiency of laboratory confirmation of the clinical diagnosis of pertussis and pertussis-like illnesses the genodiagnostic of a pertussis is recommended to improve taking into account identification DNA of B. holmesii.

1. Cherry JD, Pertussis and other Bordetella infections. In: Cherry JD, Demmler-Harrison G, Kaplan S., editors. Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed.; 2013; ISBN: 9780323392822; https://www.elsevier.com/books/feigin-and-cherrys-textbook-of-pediatric-infectious-diseases/unknown/978-0-323-39281-5

2. Lobzin, Y.V., etc. The cliniko-epidemiological character- istic of whooping cough at children of the first months of life. / Y.V. Lobzin // Children’s infections. 2011; 10(4): 5-9. https://elibrary.ru/item.asp?id=17070355

3. Petrova, M.S. Whooping cough at children of early age. / M.S. Petrova // Epidemiology and infectious diseases. 2012; 6:12-24. https://elibrary.ru/item.asp?id=18784227

4. Popova, O.P. Clinical features of whooping cough at adults. / O.P. Popova // Therapeutic archive. 2014; 86(11):78-81. https://elibrary.ru/item.asp?id=22880660

5. Rodgers L, Martin SW, Cohn A, et al. Epidemiologic and Laboratory Features of a Large Outbreak of Pertussis-Like Ill- nesses Associated With Cocirculating Bordetella holmesii and Bordetella pertussis – Ohio, 2010-2011. Clin. Infect. Dis. 2013; 56(3): 322-331.DOI:10.1093/cid/cis888; https://www.ncbi.nlm. nih.gov/pubmed/23087388

6. Kamiya H, Otsuka N, Ando Y, et al. Transmission of Bor- detella holmesii during pertussis outbreak, Japan. Emerg. In- fect. Dis. 2012; 18(7): 1166-1169. DOI: 10.3201/eid1807.120130; https://www.ncbi.nlm.nih.gov/pubmed/22709586

7. Guthrie JL, Robertson AV, Tang P, et al. Novel duplex real- time PCR assay detects Bordetella holmesii in specimens from patients with pertussis-like symptoms in Ontario, Canada. J. Clin. Microbiol. 2010; 48: 1435-1437. DOI: 10.1128/JCM.02417-09; https://www.ncbi.nlm.nih.gov/pubmed/20181919

8. Njamkepo E, Bonacorsi S, Debruyne M, et al. Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis. J Clin. Micro- biol. 2011; 49: 4347-4348. DOI: 10.1128/JCM.01272-11; https://www.ncbi.nlm.nih.gov/pubmed/22012009

9. Bottero D, Griffith MM, Lara C, et al. Bordetella holme- sii in children suspected of pertussis in Argentina. Epidemiol. Infect. 2013; 141: 714-717. DOI: 10.1017/S095026881200132X; https://www.ncbi.nlm.nih.gov/pubmed/22874073

10. Miranda C, Porte L, Garcia P. Bordetella holmesii in na- sopharyngeal samples from Chilean patients with suspected Bordetella pertussis infection. J. Clin. Microbiol. 2012; 50: 1505. DOI: 10.1128/JCM.06747-11; https://www.ncbi.nlm.nih.gov/pubmed/22427606

11. Fong W, Timms V, Holmes N, et al. Detection and incidence of Bordetella holmesii in respiratory speci- mens from patiens with pertussis-like symptoms in New South Wales, Australia. Pathology. 2018; 50: 322-326. DOI: 10.1016/j.pathol.2017.10.014; https://www.ncbi.nlm.nih.gov/pubmed/29455870

12. Mooi FR, Bruisten S, Linde I, et al. Characterization of Bordetella holmesii isolates from patients with pertussis-like ill- ness in Netherlands. FEMS Immunol. Med. Microbiol. 2012; 64: 289-291. doi: 10.1111/j.1574-695X.2011.00911.x. https://www.ncbi.nlm.nih.gov/pubmed/22098551

13. Lotfi MN, Nikbin VS, Nasiri O, et al. Molecular detec- tion of Bordetella holmesii in two infants with pertussis-like syndrome: the first report from Iran. Iranian Journal of Mi- crobology. 2017; 9(4): 219-223. https://www.ncbi.nlm.nih.gov/pubmed/?term=Lotfi+MN+2017

14. Mir-Cros A, Codina G, Martin-Gomez TM, et al. Emer- gence of Bordetella holmesii as a Causative Agent of Whoop- ing Cough, Barcelona, Spain. Emerg. Infect. Dis. 2017; 23 (11): 1856-1859. DOI: 10.3201/eid2311.170960; https://www.ncbi.nlm.nih.gov/pubmed/29052540

15. Yih WK, Silva EA, Ida J, et al. Bordetella holmesii- Like Organisms Isolated from Massachusetts Patiens with Pertussis Like Symptoms, Boston, Massachusetts, USA. Emerg. Infect. Dis. 1999; 5(3): 441-443. DOI:10.3201/eid0503.990317; https://www.ncbi.nlm.nih.gov/pubmed/10341183

16. Dinu S, Guillot S, Dragomirescu CC, et al. Whooping cough in south-East Romania: a 1-year study. Diagn. Microbiol . Dis. 2014; 78: 302-306. DOI: 10.1016/j.diagmicrobio.2013.09.017; https://www.ncbi.nlm.nih.gov/pubmed/24355701

17. Katfy K, Guiso N, Diawara I, et al. Epidemiology of per- tussis in Casablanca (Morocco): contribution of conventional and molecular diagnosis tools. BMC Infect. Dis. 2017; 17: 348. DOI: 10.1186/s12879-017-2452-3; https://www.ncbi.nlm.nih.gov/pubmed/28511667

18. Kamachi K, Yoshino S, Katsukawa C. et al. Laboratory- based surveillance of pertussis using multitarget real-time PCR in Japan: evidence for Bordetella pertussis infection in pre- teens and teens. New Microbes New Infect. 2015; 8:70-4. DOI: 10.1016/j.nmni.2015.10.001. https://www.ncbi.nlm.nih.gov/pubmed/27076914

19. Weyant RS, Hollis DG, Weaver RE, et al. Bordetella holmesii sp. now., a new gram-negative species associated with septicemia. J. Clin. Microbiol .1995; 33: 1-7. PMC227868; https://www.ncbi.nlm.nih.gov/pubmed/7699023

20. Shepard CW, Daneshwar MI, Kaiser RM, et al. Bor- detella holmesii bacteremia: A newly recognized clinical en- tity among asplenic patients. Clin. Infect. Dis. 2004; 38: 799- 804.DOI:10.1086/381888; https://www.ncbi.nlm.nih.gov/pubmed/?term=Shepard+CW+2004

21. Antila M, He Q, De Jong C, et al. Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J. Med. Microbiol. 2006; 55: 1043-1051. DOI:10.1099/jmm.0.46331-0 https://www. ncbi.nlm.nih.gov/pubmed/16849724

22. Pittet LF, Posfay-Barbe KM. Bordetella holmesii: Still Emerging and Elusive 20 Years On. Microbiology Spectrum. 2016 ;4(2): 1-12. DOI: 10.1128/microbiolspec.EI10-0003-2015; https://www.ncbi.nlm.nih.gov/pubmed/27227292

23. Williams MM, Taylor TH, Jr., Warshauer DM, et al. Har- monization of Bordetella pertussis real-time PCR diagnostics in the United States in 2012. J. Clin. Microbiol. 2015; 53: 118-123. DOI: 10.1128/JCM.02368-14; https://www.ncbi.nlm.nih.gov/pubmed/25355770

24. Mazengia E, Silva EA, Peppe JA, et al. Recovery of Bordetella holmesii from patients with pertussis-like symp- toms: use of pulsed-field gel electrophoresis to characterize circulating strains. J. Clin. Microbiol. 2000; 38: 2330- 2333. PMCID:PMC86794; https://www.ncbi.nlm.nih.gov/pubmed/?term=Mazengia+E+2000

25. Matoo S, Cherry JD. Molecular pathogenesis, epidemi- ology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 2005; 18: 326-382 DOI:10.1128/CMR.18.2.326-382.2005; https://www.ncbi.nlm.nih.gov/pubmed/15831828

26. Harvill ET, Goodfield LL, Ivanov Y, et al. Genome Se- quences of Nine Bordetella holmesii Strains Isolated in the United States. Genome Announc. 2014; 2(3): pii: e00438-14. DOI: 10.1128/genomeA.00438-14; https://www.ncbi.nlm.nih.gov/pubmed/24948754

27. Riffelmann M, Von Konig CW, Caro V, et al. Nucleic acid amplification tests for diagnosis of Bordetella infections. J. Clin. Microbiol. 2005; 43: 4925-4929. DOI:10.1128/JCM.43.10.4925-4929.2005; https://www.ncbi.nlm.nih.gov/pubmed/16207944

28. Tizolova A, Guiso N, Guillot S. Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome. Eur. J. Clin. Microbiol. Infect Dis. 2013; 32: 89-96. DOI: 10.1007/s10096-012-1718-3. https://www.ncbi.nlm.nih.gov/pubmed/?term=Tizolova+A+2013

29. Dalby T, Fry NK, Krogfelt KA, et al. Evaluation of PCR methods for the diagnosis of pertussis by the European surveil- lance network for vaccine-preventable diseases (EUVAC.NET). Eur. J. Clin. Microbiol. Infect. Dis. 2013; 32: 1285-1289. DOI: 10.1007/s10096-013-1874-0. https://www.ncbi.nlm.nih.gov/pubmed/23609510

30. Zhang X, Weyrich LS, Lavine JS, et al. Lack of cross-protection against Bordetella holmesii after pertus- sis vaccination. Emerg. Infect. Dis. 2012; 18: 1771-1779. DOI: 10.3201/eid1811.111544. https://www.ncbi.nlm.nih.gov/pubmed/23092514